Beam Therapeutics is trading 4% up today at $27.39 as the stock stages a technical bounce following an extended period of selling pressure.
- Shares are rebounding from an eight-session, ~27% slide that was previously driven by profit-taking and fading momentum.
- With no fresh company-specific news or analyst calls reported this morning, today’s move appears to be a recovery alongside a modestly positive broader market as investors step back into the stock.